Related Experiment Video
Updated: May 23, 2026

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Transforming growth factor-β and smooth muscle differentiation
1Xia Guo, Shi-You Chen, Department of Physiology and Pharmacology, University of Georgia, Athens, GA 30602, United States.
Abstract:
Transforming growth factor (TGF)-β family members are multifunctional cytokines regulating diverse cellular functions such as growth, adhesion, migration, apoptosis, and differentiation. TGF-βs elicit their effects via specific type I and type II serine/threonine kinase receptors and intracellular Smad transcription factors. Knockout mouse models for the different components of the TGF-β signaling pathway have revealed their critical roles in smooth muscle cell (SMC) differentiation. Genetic studies in humans have linked mutations in these signaling components to specific cardiovascular disorders such as aorta aneurysm and congenital heart diseases due to SMC defects. In this review, the current understanding of TGF-β function in SMC differentiation is highlighted, and the role of TGF-β signaling in SMC-related diseases is discussed.
Insights
Transforming growth factor-beta (TGF-β) signaling is crucial for smooth muscle cell (SMC) differentiation. Dysregulation of this pathway contributes to cardiovascular diseases linked to SMC defects.
Area of Science:
- Cell Biology
- Molecular Biology
- Cardiovascular Research
Background:
- Transforming growth factor-beta (TGF-β) family members are key regulators of cellular processes, including differentiation.
- TGF-β signaling involves specific serine/threonine kinase receptors and Smad transcription factors.
- Smooth muscle cell (SMC) differentiation is vital for cardiovascular health.
Purpose of the Study:
- To review the role of TGF-β signaling in SMC differentiation.
- To discuss the involvement of TGF-β in SMC-related cardiovascular diseases.
Main Methods:
- Literature review of studies on TGF-β signaling.
- Analysis of knockout mouse models for TGF-β pathway components.
- Examination of human genetic studies linking mutations to cardiovascular disorders.
Main Results:
- TGF-β signaling components are essential for SMC differentiation.
- Mutations in TGF-β pathway genes are associated with cardiovascular diseases like aortic aneurysms and congenital heart defects.
- Defects in SMCs due to aberrant TGF-β signaling underlie these pathologies.
Conclusions:
- TGF-β signaling plays a critical role in maintaining SMC function and differentiation.
- Understanding TGF-β's role is crucial for developing therapeutic strategies for SMC-related cardiovascular diseases.
More Related Videos
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Related Concept Videos
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Forced Transdifferentiation
Artificial transdifferentiation occurs...
Introduction to Fibroblasts
Master Transcription Regulators
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...